⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692857 | 1.00 | — | — | |
| SCHEMBL874522 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL22711535 | 0.98 | GABRR1 (0.96) | — | |
| SCHEMBL4077485 | 0.82 | GABRR1 (0.69) | — | |
| SCHEMBL22659954 | 0.82 | — | — | |
| SCHEMBL19506521 | 0.78 | GABRR1 (0.64) | — | |
| SCHEMBL6255571 | 0.78 | GABRR1 (0.64) | — | |
| SCHEMBL23299695 | 0.77 | GABRR1 (0.62) | — | |
| SCHEMBL22659291 | 0.77 | GABRR1 (1.00) | — | |
| SCHEMBL13046000 | 0.77 | GABRR1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021062048-A2 | METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-04-01 | — | — | WO | claimed |
| US-20160193166-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-07-07 | — | — | US | claimed |
| US-9308260-B2 | Anticonvulsive pharmaceutical compositions | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-04-12 | — | — | US | claimed |
| US-20120157532-A1 | Method Of Treating Or Preventing A Convulsive Disorder In A Patient In Need Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2012-06-21 | — | — | US | claimed |
| EP-2421523-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2012-02-29 | — | — | EP | claimed |
| WO-2010121969-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2010-10-28 | — | — | WO | claimed |
| US-20100184707-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2010-07-22 | — | — | US | claimed |
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | claimed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | claimed |
| EP-2011491-A1 | Anticonvulsive pharmaceutical compositions | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-07 | — | — | EP | claimed |
| US-20230128194-A1 | METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-04-27 | — | — | US | disclosed |
| WO-2021203033-A2 | METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021062048-A2 | METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-04-01 | — | — | WO | disclosed |
| US-20160193166-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-07-07 | — | — | US | disclosed |
| US-9308260-B2 | Anticonvulsive pharmaceutical compositions | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-04-12 | — | — | US | disclosed |
| US-20100184707-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2010-07-22 | — | — | US | disclosed |
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | disclosed |
| EP-2011491-A1 | Anticonvulsive pharmaceutical compositions | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-07 | — | — | EP | disclosed |
| US-20070155731-A1 | Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity | MERCK SHARP & DOHME CORP. | 2007-07-05 | — | — | US | disclosed |